4-154606827-A-G
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_021870.3(FGG):c.1007T>C(p.Met336Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_021870.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGG | NM_021870.3 | c.1007T>C | p.Met336Thr | missense_variant | Exon 8 of 9 | ENST00000336098.8 | NP_068656.2 | |
FGG | NM_000509.6 | c.1007T>C | p.Met336Thr | missense_variant | Exon 8 of 10 | NP_000500.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Identified in the heterozygous state in patients with dysfibrinogenemia in the published literature, including one apparently de novo occurrence (PMID: 19949684) (PMID: 2496144, 19949684, 19923982, 22836217); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also referred to as fibrinogen Asahi and Yecheon, and by alternate nomenclature p.(M310T); This variant is associated with the following publications: (PMID: 22836217, 19949684, 2496144, 19923982) -
FGG-related disorder Pathogenic:1
The FGG c.1007T>C variant is predicted to result in the amino acid substitution p.Met336Thr. This variant, also known as Met310Thr by legacy nomenclature, has been reported in individuals with Dysfibrinogenemia (Yamazumi et al. 1989. PubMed ID: 2496144; Park et al. 2009. PubMed ID: 19949684; Miesbach et al 2010. PubMed ID: 19923982; Shigekiyo et al. 2012. PubMed ID: 22836217). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant is interpreted as pathogenic. -
Familial dysfibrinogenemia Pathogenic:1
Variant summary: FGG c.1007T>C (p.Met336Thr) (legacy name p.Met310Thr) results in a non-conservative amino acid change located in the Fibrinogen, alpha/beta/gamma chain, C-terminal globular domain (IPR002181) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251364 control chromosomes. c.1007T>C has been reported in the literature with different common names such as Fibrinogen Asahi, Fibrinogen Yecheon, Fibrinogen Tokushima II in individuals affected with Congenital Dysfibrinogenemia (example, Yamazumi_1989, Park_2009, Shigekiyo_2012, Miesbach_2010). Some of these reports indicated this variant as a heterozygous de-novo occurrence in the affected proband. It is known to result in subsequent extra N-glycosylation at the gamma Asn 308 (Yamazumi_1989). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
FIBRINOGEN ASAHI Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at